Β-lactam antibiotic reactions to any β-lactam antibiotic may occur in up to 10% of patients receiving that agent (a small fraction of which are truly IgE-mediated allergic reactions, see amoxicillin rash). Anaphylaxis will occur in approximately 0.01% of patients. There is perhaps a 5%-10% cross-sensitivity between penicillin-derivatives, cephalosporins, and carbapenems; but this figure has been challenged by various investigators. Nevertheless, the risk of cross-reactivity is sufficient to warrant the contraindication of all β-lactam antibiotics in patients with a history of severe allergic reactions (urticaria, anaphylaxis, interstitial nephritis) to any β-lactam antibiotic. A Jarisch–Herxheimer reaction may occur after initial treatment of a spirochetal
Antibiotic use in livestock for not collecting enough information and data on antibiotic use in factory farms. From this, the GAO concluded that the FDA does not have enough information to create effective policy changes regarding antibiotic use. In response, the FDA insisted that more research was being conducted and voluntary efforts within the industry would solve the problem of antibiotic resistance. Few policies exist that limit antibiotic use on factory farms, and some proposed legislation in the US has failed to be adopted. In 2007, two federal bills (S. 549 and H.R. 962) aimed to phase out nontherapeutic antibiotics in U.S. food animal